Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
Biography and Research Information
OverviewAI-generated summary
Rajiv Pathak's research focuses on understanding disease mechanisms through integrated network pharmacology and molecular simulations. His work investigates the role of specific biomarkers, such as Interleukin-10, in conditions like COVID-19, exploring potential therapeutic targets. Pathak has also studied novel compounds for their effects on cancer cells, specifically examining non-apoptotic cell death pathways in triple-negative breast cancer. His research collaborations include work with Mary Qu Yang from the University of Arkansas at Little Rock, with whom he has co-authored publications. Pathak's scholarly output includes a h-index of 2, with 3 total publications and 7 citations.
Metrics
- h-index: 2
- Publications: 3
- Citations: 9
Selected Publications
-
Abstract LB315: Targeting endolysosomal trafficking to overcome paclitaxel resistance in triple-negative breast cancer (2026)
-
Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells (2024)
Collaboration Network
Top Collaborators
Saloni Malla
University of Toledo (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Angelique Nyinawabera
University of Toledo (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Rabin Neupane
University of Toledo (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Donghyun Lee
University of Toledo (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Mariam Sami Abou-Dahech
University of Toledo (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Shikha Kumari
University of Toledo (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Suman Sinha
GLA University (IN)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Yuan Tang
University of Toledo (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Aniruddha Ray
University of Toledo (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Charles R. Ashby
St. John's University (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Mary Qu Yang
University of Arkansas for Medical Sciences
1 shared publication
In database
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
R. Jayachandra Babu
Auburn University (US)
1 shared publication
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Amit K. Tiwari
University of Toledo
1 shared publication
In database
- Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Similar Researchers
Based on overlapping research topics
Anita Naushir Akbar Ali
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Roger G. Rank
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Pharmacological Effects and Toxicity Studies
Immune Response and Inflammation
J. Y. Suen
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Disease Mechanisms Research
Pharmacological Effects and Toxicity Studies
Na Li
Harding University Main Campus
SARS-CoV-2 and COVID-19 Research
Disease Mechanisms Research
Bioinformatics and Genomic Networks
Lance Calhoon
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Elsherbini, Medhat
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Pharmacological Effects and Toxicity Studies
Immune Response and Inflammation